The Schall Law Firm has initiated a securities fraud class action lawsuit against Picard Medical, Inc., targeting investors who purchased company securities during a specific eight-week window in fall 2025. According to the filing, Picard Medical allegedly engaged in a coordinated scheme involving false and misleading public statements designed to artificially elevate share prices during the September 2 through October 31, 2025 period.
The litigation centers on allegations that company insiders capitalized on artificially inflated valuations by executing significant share sales while the manipulation was ongoing. Shareholders who sustained losses during this timeframe are eligible to participate as lead plaintiffs in the action, which could affect their ability to recover damages.
Investors seeking to join the class action must act by April 3, 2026. The Schall Law Firm is currently accepting inquiries from affected shareholders to determine case scope and potential recovery amounts. Legal counsel advises affected investors to document their transaction records and timeline of purchases during the alleged fraud period.